Complementary findings were observed by Xiong et al., 2022 who showed that decitabine combined with docetaxel reactivated the tumor suppressor DAB2IP, thereby modulating the AKT and β-catenin signaling axes and enhancing apoptotic responses [69]. The gene discussed is DAB2IP; the disease is neoplasm.